MS Panel Offers

Quote
anonymous said:
I interviewed recently and received a phone call from P1 within 1 business day letting me know I was under active consideration and that I was being sent links to complete a background check and reference request. Is it safe to assume I am the selected candidate? I know background checks are somewhat costly.
Click to expand...

You would have to be the selected candidate. You are lucky they got back with you on one business day. I have not heard of something moving that fast. Would love to hear everyone else's thoughts on this. Could it be that you were the last day of interviewing for that territory? Most people have said they would get back to them in a couple of weeks because they were still actively interviewing candidates for that territory. In other words, I think some territories required interviews over a course of at least a couple of weeks due to availability etc.
So if a candidate was interviewed during week one but then they were also interviewing candidates for the same position during week 2, then they couldn't possibly move that quickly unless you were the final candidate being interviewed.
 






anonymous said:
You would have to be the selected candidate. You are lucky they got back with you on one business day. I have not heard of something moving that fast. Would love to hear everyone else's thoughts on this. Could it be that you were the last day of interviewing for that territory? Most people have said they would get back to them in a couple of weeks because they were still actively interviewing candidates for that territory. In other words, I think some territories required interviews over a course of at least a couple of weeks due to availability etc.
So if a candidate was interviewed during week one but then they were also interviewing candidates for the same position during week 2, then they couldn't possibly move that quickly unless you were the final candidate being interviewed.
Click to expand...

Thank you. I am hopeful. I know they were still interviewing several people across the country this week. I was told offers would be made May 23rd and even possibly towards the end of this week depending on when you interviewed.

I wouldn't assume you are out by any means. It depends on who may still have to interview and even the selected person could say no at the end of the day. Good luck. Ultimately, I was told over 6k people did apply for these jobs.
 






anonymous said:
I interviewed recently and received a phone call from P1 within 1 business day letting me know I was under active consideration and that I was being sent links to complete a background check and reference request. Is it safe to assume I am the selected candidate? I know background checks are somewhat costly.
Click to expand...

Congrats, but why the hurry? What fool already employed would leave for a drug which is not yet approved? It has happened before and reps call their former employer and say 'take me back'!. RISKY.
 






anonymous said:
Thank you. I am hopeful. I know they were still interviewing several people across the country this week. I was told offers would be made May 23rd and even possibly towards the end of this week depending on when you interviewed.

I wouldn't assume you are out by any means. It depends on who may still have to interview and even the selected person could say no at the end of the day. Good luck. Ultimately, I was told over 6k people did apply for these jobs.
Click to expand...

Thank you ....u too!
 






anonymous said:
Congrats, but why the hurry? What fool already employed would leave for a drug which is not yet approved? It has happened before and reps call their former employer and say 'take me back'!. RISKY.
Click to expand...

An unapproved drug is risky, but it's Genentech, more $$$, and I do happen to think the data is generally positive. Clearly, I'm not the only one willing to jump from a good situation considering the high volume of applicants. Nothing in this industry is stable, but I will ride the train until it's time to move on.
 






anonymous said:
An unapproved drug is risky, but it's Genentech, more $$$, and I do happen to think the data is generally positive. Clearly, I'm not the only one willing to jump from a good situation considering the high volume of applicants. Nothing in this industry is stable, but I will ride the train until it's time to move on.
Click to expand...

Ride the train? It may never leave the station! Job hoppin in this industry gets you nowhere in the end.
 






anonymous said:
Ride the train? It may never leave the station! Job hoppin in this industry gets you nowhere in the end.
Click to expand...

I am in no way a job hopper. You misinterpreted my comment. My point was the whole pharmaceutical and device industry is unstable. Total health care expenditures continue to rise and prescription drug costs are at an all time high. So, where do you think those cost cutting measures will hit most? So, yes I will collect my bloated paycheck until it is over. I have degrees and connections to actually use once I do have to get out of the industry entirely. You sound bitter, but I still wish you luck if you are competing for an MS position.
 












anonymous said:
Why would they spend money on background checks BEFORE they know if you will aaccpet their offer.....interesting.
Click to expand...

It's anyone's guess. I have now heard so many stories and not sure what to believe anymore. I last heard from P1 that I was still in running, but never asked for anything additional other than the envelop of paperwork we gave at interview. If it's meant to be it will be I guess.
 






anonymous said:
Why would they spend money on background checks BEFORE they know if you will aaccpet their offer.....interesting.
Click to expand...

I am an internal and was given an offer. I did find out one interesting fact about our S.SF summer training-they will have roommates. After five years here, whether training or sales meetings, we got our own room. What gives? Seems like a legal risk to me, what gives?
 






Here's why I backed out of the second round. 1. Didn't want to waste my time nor the managers time. I'd rather see someone who really wants the spot get moved on instead of me who had second thoughts...here's why. 1. The drug will be launched in PPMS where it will 99% be approved based on the data. The RRMS data will also most likely get approved, at a third or fourth line if formularies allow it. 2. It will be a risky drug to write if the patient was on Lemtrada, Tysabri , etc.. Because of PML, opportunistic infections. The market is flooded with 12 drugs now, this one and another this year alone. Not including the ones in que for the next few years. (Think hypertension market 2008) 3. The territories are small...real small for a difficult, expensive, limited indication drug. Unless you have a few MS centers in your area, I would be concerned. 4. Roche runs the show now, look at the little asterisk on the website next to the product. (Means managed by Roche) . If it doesn't go as planned.....they will downsize, it's the big pharma way. To those of you that take the spot, I wish you well. Good luck. It's better than a lot that's out there and with a good company.....
 






anonymous said:
Here's why I backed out of the second round. 1. Didn't want to waste my time nor the managers time. I'd rather see someone who really wants the spot get moved on instead of me who had second thoughts...here's why. 1. The drug will be launched in PPMS where it will 99% be approved based on the data. The RRMS data will also most likely get approved, at a third or fourth line if formularies allow it. 2. It will be a risky drug to write if the patient was on Lemtrada, Tysabri , etc.. Because of PML, opportunistic infections. The market is flooded with 12 drugs now, this one and another this year alone. Not including the ones in que for the next few years. (Think hypertension market 2008) 3. The territories are small...real small for a difficult, expensive, limited indication drug. Unless you have a few MS centers in your area, I would be concerned. 4. Roche runs the show now, look at the little asterisk on the website next to the product. (Means managed by Roche) . If it doesn't go as planned.....they will downsize, it's the big pharma way. To those of you that take the spot, I wish you well. Good luck. It's better than a lot that's out there and with a good company.....
Click to expand...

Best post on this thread, hands down.

:);):)
 












anonymous said:
Here's why I backed out of the second round. 1. Didn't want to waste my time nor the managers time. I'd rather see someone who really wants the spot get moved on instead of me who had second thoughts...here's why. 1. The drug will be launched in PPMS where it will 99% be approved based on the data. The RRMS data will also most likely get approved, at a third or fourth line if formularies allow it. 2. It will be a risky drug to write if the patient was on Lemtrada, Tysabri , etc.. Because of PML, opportunistic infections. The market is flooded with 12 drugs now, this one and another this year alone. Not including the ones in que for the next few years. (Think hypertension market 2008) 3. The territories are small...real small for a difficult, expensive, limited indication drug. Unless you have a few MS centers in your area, I would be concerned. 4. Roche runs the show now, look at the little asterisk on the website next to the product. (Means managed by Roche) . If it doesn't go as planned.....they will downsize, it's the big pharma way. To those of you that take the spot, I wish you well. Good luck. It's better than a lot that's out there and with a good company.....
Click to expand...

Wow talk about the voice of sanity with facts.

MS market is new to Roche ran by Swiss banker types vs. GNE mgmnt in dire need of new homerun molecule along with the marketing peeps hoping for the gangbuster launch and sales - I'd say 50:50 on success on Ocre.

Given the ongoing unsettling rumours of RIF at GNE all may not be well below the hood as after all Roche closed ex-US HQ Nutley, Boulder CO, Palo Alto CA and soon Florence SC as it's all about #s... And the reason for RIF rumors are the biosimilar challenges to Onc stalwarts Avastin, Herceptin and Rituxan (also RA) around the corner.
 












anonymous said:
I am in no way a job hopper. You misinterpreted my comment. My point was the whole pharmaceutical and device industry is unstable. Total health care expenditures continue to rise and prescription drug costs are at an all time high. So, where do you think those cost cutting measures will hit most? So, yes I will collect my bloated paycheck until it is over. I have degrees and connections to actually use once I do have to get out of the industry entirely. You sound bitter, but I still wish you luck if you are competing for an MS position.
Click to expand...

Exactly. Good for you. Take the raise and broaden your skills. If Genentech doesn't work out, you will have experience with different skills. Lots of people join a company and act very blue collar in marrying a company. One day they get let go and have no competitive skills to offer.
 












anonymous said:
Here's why I backed out of the second round. 1. Didn't want to waste my time nor the managers time. I'd rather see someone who really wants the spot get moved on instead of me who had second thoughts...here's why. 1. The drug will be launched in PPMS where it will 99% be approved based on the data. The RRMS data will also most likely get approved, at a third or fourth line if formularies allow it. 2. It will be a risky drug to write if the patient was on Lemtrada, Tysabri , etc.. Because of PML, opportunistic infections. The market is flooded with 12 drugs now, this one and another this year alone. Not including the ones in que for the next few years. (Think hypertension market 2008) 3. The territories are small...real small for a difficult, expensive, limited indication drug. Unless you have a few MS centers in your area, I would be concerned. 4. Roche runs the show now, look at the little asterisk on the website next to the product. (Means managed by Roche) . If it doesn't go as planned.....they will downsize, it's the big pharma way. To those of you that take the spot, I wish you well. Good luck. It's better than a lot that's out there and with a good company.....
Click to expand...



I agree w/ all you stated!
 












anonymous said:
I don't think offers have been extended and truly in the end, the date will be May 23
Click to expand...

A few reps in my franchise do have confirmed offers so maybe the 23rd is the date for the candidates that are the 2nd choice. They are extending offers to the reps they are 100% on and then seeing who declines offers before moving down the list.
 






Top Bottom
Back
Quote